MAP2K7

Dual specificity mitogen-activated protein kinase kinase 7, also known as MAP kinase kinase 7 or MKK7, is an enzyme that in humans is encoded by the MAP2K7 gene.[5] This protein is a member of the mitogen-activated protein kinase kinase family. The MKK7 protein exists as six different isoforms with three possible N-termini (α, β, and γ isoforms) and two possible C-termini (1 and 2 isoforms).[6]

MAP2K7
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 2DYL, 3WZU, 4UX9, 5B2K, 5B2L, 5B2M
Identifiers
Aliases	MAP2K7, JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7, SAPKK-4, SAPKK4, mitogen-activated protein kinase kinase 7
External IDs	OMIM: 603014 MGI: 1346871 HomoloGene: 56548 GeneCards: MAP2K7
Gene location (Human) Chr. Chromosome 19 (human)[1] Band 19p13.2 Start 7,903,843 bp[1] End 7,914,478 bp[1]
Gene location (Mouse) Chr. Chromosome 8 (mouse)[2] Band 8|8 A1.1 Start 4,238,740 bp[2] End 4,247,897 bp[2]
Gene ontology Molecular function • metal ion binding • nucleotide binding • protein tyrosine kinase activity • protein kinase binding • protein kinase activity • magnesium ion binding • transferase activity • kinase activity • ATP binding • enzyme binding • protein phosphatase binding • GO:0001948 protein binding • MAP kinase kinase activity • protein serine/threonine kinase activity • JUN kinase kinase activity Cellular component • cell nucleus • cytoplasm • cytosol Biological process • response to UV • signal transduction • positive regulation of telomerase activity • positive regulation of telomere maintenance via telomerase • positive regulation of telomere capping • apoptotic process • response to osmotic stress • peptidyl-tyrosine phosphorylation • response to tumor necrosis factor • protein phosphorylation • response to heat • phosphorylation • stress-activated MAPK cascade • activation of JUN kinase activity • regulation of mitotic cell cycle • regulation of apoptotic process • activation of MAPK activity • signal transduction by protein phosphorylation • stress-activated protein kinase signaling cascade • activation of protein kinase activity • positive regulation of transcription, DNA-templated • positive regulation of ERK1 and ERK2 cascade • JNK cascade • Fc-epsilon receptor signaling pathway Sources:Amigo / QuickGO
Orthologs
Species	Human	Mouse
Entrez	5609	26400
Ensembl	ENSG00000076984	ENSMUSG00000002948
UniProt	O14733	Q8CE90
RefSeq (mRNA)	NM_001297555 NM_001297556 NM_145185	NM_001042557 NM_001164172 NM_001291777 NM_001291778 NM_001291783 NM_011944
RefSeq (protein)	NP_001284484 NP_001284485 NP_660186	NP_001036022 NP_001157644 NP_001278706 NP_001278707 NP_001278712 NP_036074
Location (UCSC)	Chr 19: 7.9 – 7.91 Mb	Chr 8: 4.24 – 4.25 Mb
PubMed search	[3]	[4]
Wikidata
View/Edit Human View/Edit Mouse

MKK7 is involved in signal transduction mediating the cell responses to proinflammatory cytokines, and environmental stresses. This kinase specifically activates MAPK8/JNK1 and MAPK9/JNK2, and this kinase itself is phosphorylated and activated by MAP kinase kinase kinases including MAP3K1/MEKK1, MAP3K2/MEKK2, MAP3K3/MEKK5, and MAP4K2/GCK.

MKK7 is ubiquitously expressed in all tissue. However, it displays a higher level of expression in skeletal muscle.[7] Multiple alternatively spliced transcript variants encoding distinct isoforms have been found.[5]

Nomenclature

MAP2K7 is also known as:

• MKK7
• JNK-activated kinase 2
• MAPK/ERK kinase 7 (MEK7)
• Stress-activated protein kinase kinase 4 (SAPK kinase 4, SAPKK4)
• c-Jun N-terminal kinase kinase 2 (JNK kinase 2, JNKK2)
• Stress-activated / extracellular signal-regulated protein kinase kinase 2 (SEK2)

Isoforms

The murine MKK7 protein is encoded by 14 exons which can be alternatively spliced to yield a group of protein kinases. This results in six isoforms with three possible N-termini (α, β, and γ isoforms) and two possible C-termini (1 and 2 isoforms). The molecular mass of the isoforms spans from 38 to 52 kDa, with between 345 and 467 amino acids.[6]

The physiological relevance of the different MKK7 isoforms is still unclear. Evidence shows that the MKK7α, which lacks an NH2-terminal extension, shows a lower basal activity in binding JNK compared to the MKKβ and γ isoforms. The increased basal activity in the β and γ isoforms can be due to the three D-motifs present in the N-terminus of these isoforms.[8]

Structure and function

The architecture of MKK7: Box-model illustration of the structure of MKK7.[9]

D-motifs

MKK7 has three conserved D-motifs (MAPK-recruiting short linear motifs) on its intinsically disordered N-terminus. D-motifs typically consist of a cluster of positively charged amino acids followed by alternating hydrophobic amino acids.[8] D-motifs are strictly required for the recruitment of MAPKK substrates, such as JNK.[10] The kinase domains of MAPKs contain certain surface features, such as the so-called common docking (CD) region, alongside the docking (D) groove, that specifically recognize their cognate D-motifs.[8] The D-motifs found in MKK7 are highly specific for JNKs, but have a relatively low binding affinity. It was suggested that the motifs of MKK7 can synergize with each other to provide an efficient substrate phosphorylation[11] It has been shown that all three D-motifs are necessary for correct JNK1:MKK7 complex formations, and for the phosphorylation and activation of JNK1 by MKK7.[12]

DVD region

A special extension to the C-terminal kinase domain core, the so-called "Domain for Versatile Docking" (DVD) is a region found in MKK7 as in most known MAP2Ks,.[10] The DVD region is a stable, mostly helical fold of roughly 20 amino acids, that adds onto the back side of the catalytic core of the MAP2K kinase domains.[13] This domain extension is both required for the specific binding to, and activation of MKK7 by respective upstream MAPKKKs. Other mitogen activated protein kinase kinases also require the DVD region (in addition to various other non-canonical elements of their kinase domains, like the "MKK1/2-loop") to be able to discriminate against the various MAPKKK upstream.[14] These special MAPKK:MAPKKK kinase-domain/kinase-domain interactions facilitate the phosphorylation of MKK7.[8] In addition to the activation of MKK7, binding to the DVD region may also affect the MKK7 activation loop in such a way that the Ser and Thr of the S-K-A-K-T motif become accessible for phosphorylation.[8]

Kinase domain

The MKK7 contains one kinase domain. The direct MKK7:MAPKKK interaction (using the DVD region), facilitates the phosphorylation of MKK7 by MAPKKKs on serine and threonine in a S-K-A-K-T motif in the catalytic domain (kinase domain).[9]

Signaling and regulation

MKK7 play an important part in the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway.[15] In collaboration with another mitogen-activated protein kinase kinase MKK4, MKK7 work as crucial transducers upstream of JNK signaling.[16] Through joint efforts the two MKKs phosphorylate different JNK isoforms. As a result, MKK7 has a great impact on numerous physiological processes such as proliferation and differentiation, as well as pathological processes such as apoptosis and tumorigenesis.[9] MKK7 are activated as a result of cellular stresses.[16] They are activated by a number of MKKKs through phosphorylation at a S-K-A-K-T motif located in the MKK7s kinase domain. The MKKKs relate to MKK7 through its DVD site at the C-terminus and phosphorylate MKK7 at serine and threonine residues.[9] Once activated, MKK4 and MKK7 directly phosphorylate specific tyrosine and threonine residues located in the conserved T-P-Y motif of the activation loop of the JNK protein.[9] Although MKK7 act through dual specificity it tends to phosphorylate threonine on JNK protein, leaving MKK4 to phosphorylate tyrosine.[16] Phosphorylated and activated JNKs activate substrates like transcription factors or pro-apoptotic protein.[9] MKK7 and MKK4 seem to be regulating the expression of each other, thereby affecting the JNK signaling. The mono-phosphorylation of JNK on a threonine residue is adequate for the increase in JNK activity, which argues that MKK7 is an important constituent for JNK activity, while the additional phosphorylation of the tyrosine residue by MKK4 provide for a more favorable activation.[9] Overall, MAP2K7 contains multiple amino acid sites that are phosphorylated and ubiquitinated.[17]

Scaffold proteins

Scaffold protein: A tradiational model showing how a scaffold protein is envisioned to bind a MAPKKK, MAPKK and a MAPK in a multienzyme complex.[16] Note that this model is outdated for JIP1, as it does not assemble an on-scaffold kinase cascade, but provides a selective release of MKK7 and DLK in specific compartments instead[18]

In addition to the direct interactions between JNK, MKK7 and other upstream protein kinases, various scaffold proteins function to ensure specificity between the components of the MAPK signaling cascade.[8][16] Different JNK isoforms, MAPK, and MAPKKs (e.g., MKK7 or MKK4) bind specifically to the scaffold proteins. Several mammalian scaffold proteins have been identified. These include the JNK-interacting protein (JIP) 1 and its closerly-related homolog, JIP2 or the (completely unrelated) JIP3 and JIP4 proteins. Nevertheless, JIP1/2 and JIP3/4 were shown to be capable of direct interaction with each other.[19] Plenty of Src-homology-3 (POSH) has also been shown to be a partner of JIP1/2.[16]

All these JNK pathway regulators assemble transport complexes, tied to kinesin-dependent vesicular transport. In this context, JIP1/2 act as cargo adaptors, binding to a motor protein and a cargo protein simultaneously. In addition to their "normal" cargoes (C-termini of transmembrane proteins), they also transport MAP2K and MAP3K enzymes, namely MKK7, DLK and MLK3. Kinases bound to the JIP1/2 scaffold are generally sequestrated and thought to be inactive.[18] Since the cargo-linkage mechanism of this complex is believed to be phosphporylation-dependent, phosphorylation by JNK kinase can release its own upstream activators from the scaffold, thus driving a strong local positive feedback loop.[18][20]

Interactions

MAP2K7 has been shown to interact with:

• CNKSR1 [21]
• MAP3K1 [22]
• MAPK8[23][24]
• MAPK8IP3[25][26]
• MAPK8IP1[27]
• GADD45B[28]
• MAP3K12[29]
• MAP3K2[24]
• MAPK8IP2[27][30]
• DUSP19[31][32]

Biological relevance

MKK7 is involved in the development of epithelial tissues such as skin and lungs, and also the developing teeth, during early embryogenesis in mice.[8] Experiments also indicate that MKK7 in addition to MKK4 are required for mammalian body plan organization during embryogenesis.[16] MKK7 has also been suggested to function as a putative Metastase Suppressor Gene (MSG) by possibly promoting tumor dormancy at the metastatic site.[33] In small mammals, stress like pressure overload can cause cardiac hypertrophy and failure if MKK7 is knocked out.[34] Conditional deletion of Map2k7 in neural stem cells and postmitotic neurons identified a role for MKK7 in axonal elongation.[35] Neuron-specific deletion of Map2k7 showed a role for MKK7 in age-dependent motor dysfunction.[36] Genetic variations in MAP2K7 have been associated with schizophrenia in humans.[37]

References

1. GRCh38: Ensembl release 89: ENSG00000076984 - Ensembl, May 2017
2. GRCm38: Ensembl release 89: ENSMUSG00000002948 - Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. "Entrez Gene: MAP2K7 mitogen-activated protein kinase kinase 7".
6. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (February 1999). "The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases". Molecular and Cellular Biology. 19 (2): 1569–81. doi:10.1128/mcb.19.2.1569. PMC 116085. PMID 9891090.
7. Foltz IN, Gerl RE, Wieler JS, Luckach M, Salmon RA, Schrader JW (April 1998). "Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli". The Journal of Biological Chemistry. 273 (15): 9344–51. doi:10.1074/jbc.273.15.9344. PMID 9535930.
8. Wang X, Destrument A, Tournier C (August 2007). "Physiological roles of MKK4 and MKK7: insights from animal models". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773 (8): 1349–57. doi:10.1016/j.bbamcr.2006.10.016. PMID 17157936.
9. Haeusgen W, Herdegen T, Waetzig V (2011). "The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7". European Journal of Cell Biology. 90 (6–7): 536–44. doi:10.1016/j.ejcb.2010.11.008. PMID 21333379.
10. Gantert C, Honerkamp J, Timmer J (1992). "Analyzing the dynamics of hand tremor time series". Biological Cybernetics. 66 (6): 479–84. doi:10.1007/bf00204112. PMID 1586672. S2CID 22250412.
11. Ho DT, Bardwell AJ, Abdollahi M, Bardwell L (August 2003). "A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates". The Journal of Biological Chemistry. 278 (35): 32662–72. doi:10.1074/jbc.M304229200. PMC 3017503. PMID 12788955.
12. Ho DT, Bardwell AJ, Grewal S, Iverson C, Bardwell L (May 2006). "Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases". The Journal of Biological Chemistry. 281 (19): 13169–79. doi:10.1074/jbc.M601010200. PMC 3017509. PMID 16533805.
13. Raman M, Chen W, Cobb MH (May 2007). "Differential regulation and properties of MAPKs". Oncogene. 26 (22): 3100–12. doi:10.1038/sj.onc.1210392. PMID 17496909.
14. Reményi A, Good MC, Lim WA (December 2006). "Docking interactions in protein kinase and phosphatase networks". Current Opinion in Structural Biology. 16 (6): 676–85. doi:10.1016/j.sbi.2006.10.008. PMID 17079133.
15. Yao Z, Diener K, Wang XS, Zukowski M, Matsumoto G, Zhou G, et al. (December 1997). "Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase". The Journal of Biological Chemistry. 272 (51): 32378–83. doi:10.1074/jbc.272.51.32378. PMID 9405446.
16. Asaoka Y, Nishina H (October 2010). "Diverse physiological functions of MKK4 and MKK7 during early embryogenesis". Journal of Biochemistry. 148 (4): 393–401. doi:10.1093/jb/mvq098. PMID 20801953.
17. "MKK7 (human)". www.phosphosite.org. Retrieved 2020-10-28.
18. Nihalani D, Wong HN, Holzman LB (August 2003). "Recruitment of JNK to JIP1 and JNK-dependent JIP1 phosphorylation regulates JNK module dynamics and activation". The Journal of Biological Chemistry. 278 (31): 28694–702. doi:10.1074/jbc.M304212200. PMID 12756254.
19. Hammond JW, Griffin K, Jih GT, Stuckey J, Verhey KJ (May 2008). "Co-operative versus independent transport of different cargoes by Kinesin-1". Traffic. 9 (5): 725–41. doi:10.1111/j.1600-0854.2008.00722.x. hdl:2027.42/72137. PMID 18266909. S2CID 21901129.
20. Nihalani D, Wong H, Verma R, Holzman LB (April 2007). "Src family kinases directly regulate JIP1 module dynamics and activation". Molecular and Cellular Biology. 27 (7): 2431–41. doi:10.1128/MCB.01479-06. PMC 1899903. PMID 17242197.
21. Jaffe AB, Hall A, Schmidt A (March 2005). "Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho". Current Biology. 15 (5): 405–12. doi:10.1016/j.cub.2004.12.082. PMID 15753034. S2CID 16479940.
22. Karandikar M, Xu S, Cobb MH (December 2000). "MEKK1 binds raf-1 and the ERK2 cascade components". The Journal of Biological Chemistry. 275 (51): 40120–7. doi:10.1074/jbc.M005926200. PMID 10969079.
23. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (July 1997). "Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase". Proceedings of the National Academy of Sciences of the United States of America. 94 (14): 7337–42. Bibcode:1997PNAS...94.7337T. doi:10.1073/pnas.94.14.7337. PMC 23822. PMID 9207092.
24. Cheng J, Yang J, Xia Y, Karin M, Su B (April 2000). "Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation". Molecular and Cellular Biology. 20 (7): 2334–42. doi:10.1128/MCB.20.7.2334-2342.2000. PMC 85399. PMID 10713157.
25. Kelkar N, Gupta S, Dickens M, Davis RJ (February 2000). "Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3". Molecular and Cellular Biology. 20 (3): 1030–43. doi:10.1128/MCB.20.3.1030-1043.2000. PMC 85220. PMID 10629060.
26. Matsuura H, Nishitoh H, Takeda K, Matsuzawa A, Amagasa T, Ito M, et al. (October 2002). "Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK signaling pathway. A new mode of regulation of the MAP kinase cascade". The Journal of Biological Chemistry. 277 (43): 40703–9. doi:10.1074/jbc.M202004200. PMID 12189133.
27. Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ (October 1999). "The JIP group of mitogen-activated protein kinase scaffold proteins". Molecular and Cellular Biology. 19 (10): 7245–54. doi:10.1128/mcb.19.10.7245. PMC 84717. PMID 10490659.
28. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S, et al. (February 2004). "Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2". Nature Cell Biology. 6 (2): 146–53. doi:10.1038/ncb1093. PMID 14743220. S2CID 5250125.
29. Merritt SE, Mata M, Nihalani D, Zhu C, Hu X, Holzman LB (April 1999). "The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate". The Journal of Biological Chemistry. 274 (15): 10195–202. doi:10.1074/jbc.274.15.10195. PMID 10187804.
30. Negri S, Oberson A, Steinmann M, Sauser C, Nicod P, Waeber G, et al. (March 2000). "cDNA cloning and mapping of a novel islet-brain/JNK-interacting protein". Genomics. 64 (3): 324–30. doi:10.1006/geno.2000.6129. PMID 10756100.
31. Zama T, Aoki R, Kamimoto T, Inoue K, Ikeda Y, Hagiwara M (June 2002). "Scaffold role of a mitogen-activated protein kinase phosphatase, SKRP1, for the JNK signaling pathway" (PDF). The Journal of Biological Chemistry. 277 (26): 23919–26. doi:10.1074/jbc.M200838200. PMID 11959862. S2CID 12430487.
32. Zama T, Aoki R, Kamimoto T, Inoue K, Ikeda Y, Hagiwara M (June 2002). "A novel dual specificity phosphatase SKRP1 interacts with the MAPK kinase MKK7 and inactivates the JNK MAPK pathway. Implication for the precise regulation of the particular MAPK pathway". The Journal of Biological Chemistry. 277 (26): 23909–18. doi:10.1074/jbc.M200837200. PMID 11959861.
33. Naumov GN, Folkman J, Straume O, Akslen LA (2008). "Tumor-vascular interactions and tumor dormancy". APMIS. 116 (7–8): 569–85. doi:10.1111/j.1600-0463.2008.01213.x. PMC 3508681. PMID 18834403.
34. Liu W, Zi M, Chi H, Jin J, Prehar S, Neyses L, et al. (April 2011). "Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload". Journal of Molecular and Cellular Cardiology. 50 (4): 702–11. doi:10.1016/j.yjmcc.2011.01.013. PMID 21284947.
35. Yamasaki T, Kawasaki H, Arakawa S, Shimizu K, Shimizu S, Reiner O, et al. (November 2011). "Stress-activated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex". The Journal of Neuroscience. 31 (46): 16872–83. doi:10.1523/JNEUROSCI.1111-11.2011. PMC 6633308. PMID 22090513.
36. Yamasaki T, Deki-Arima N, Kaneko A, Miyamura N, Iwatsuki M, Matsuoka M, et al. (August 2017). "Age-dependent motor dysfunction due to neuron-specific disruption of stress-activated protein kinase MKK7". Scientific Reports. 7 (1): 7348. Bibcode:2017NatSR...7.7348Y. doi:10.1038/s41598-017-07845-x. PMC 5544763. PMID 28779160.
37. Winchester CL, Ohzeki H, Vouyiouklis DA, Thompson R, Penninger JM, Yamagami K, et al. (November 2012). "Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia". Human Molecular Genetics. 21 (22): 4910–21. doi:10.1093/hmg/dds331. PMID 22899651.

Further reading

• Lin A (2006). "The JNK Signaling Pathway (Molecular Biology Intelligence Unit)". Landes Bioscience. 1: 1–97. ISBN 978-1587061202.